TrialInternational journal of molecular sciences2023

The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis-A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial.

Igor Karolak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.